Cargando…

Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus

BACKGROUND: Advanced glycation end products (AGEs) that abnormally accumulate in diabetic patients have been reported to damage bone health. We aimed to investigate the association between skin autofluorescence (SAF)‐AGE(age) (SAF − AGEs × age/100) and low bone density (LBD)/osteoporosis or major os...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hongyan, Wang, Guoqi, Wu, Ting, Hu, Jia, Mu, Yiming, Gu, Weijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512774/
https://www.ncbi.nlm.nih.gov/pubmed/36058895
http://dx.doi.org/10.1111/1753-0407.13309
_version_ 1784797905799872512
author Liu, Hongyan
Wang, Guoqi
Wu, Ting
Hu, Jia
Mu, Yiming
Gu, Weijun
author_facet Liu, Hongyan
Wang, Guoqi
Wu, Ting
Hu, Jia
Mu, Yiming
Gu, Weijun
author_sort Liu, Hongyan
collection PubMed
description BACKGROUND: Advanced glycation end products (AGEs) that abnormally accumulate in diabetic patients have been reported to damage bone health. We aimed to investigate the association between skin autofluorescence (SAF)‐AGE(age) (SAF − AGEs × age/100) and low bone density (LBD)/osteoporosis or major osteoporotic fractures (MOFs) in patients with type 2 diabetes mellitus (T2DM). METHODS: This study was nested in the prospective REACTION (Risk Evaluation of Cancers in Chinese Diabetic Individuals) study and included 1214 eligible participants. SAF was used to measure skin AGEs (SAF‐AGEs). Fracture events were determined by an in‐person clinical follow‐up. Binary logistic regression analysis, linear regression analysis, and a restricted cubic spline nested in logistic models were used to test outcomes. RESULTS: The overall prevalence of LBD/osteoporosis in middle‐aged or elderly T2DM patients was 35.7% (n = 434), and the overall incidence of MOFs was 10.5% (n = 116). Logistic analysis showed a significantly positive relationship between quartiles of SAF‐AGE(age) and the risk of LBD/osteoporosis (odds ratio [OR] 2.02, 95% CI 1.34–3.03; OR 3.63, CI 2.44–5.39; and OR 6.51, CI 4.34–9.78) for the multivariate‐adjusted models, respectively. SAF‐AGE(age) was associated with MOFs with a multivariate‐adjusted OR of 1.02 (CI 0.52–2.02), 2.42 (CI 1.32–4.46), and 2.70 (CI 1.48–4.91), respectively. Stratified analyses showed that SAF‐AGE(age) was significantly associated with MOFs only in females, nonsmokers, nondrinkers, individuals with lower body mass index, and those without LBD/osteoporosis. Linear regression analyses showed that higher SAF‐AGEs were associated with a higher level of serum N‐terminal propeptide of type I procollagen (s‐PINP) and serum carboxy‐terminal cross‐linking peptide of type I collagen (s‐CTX), with a multivariate‐adjusted OR of 1.02 (CI 0.24–1.80) and 6.30 (CI 1.77–10.83), respectively. CONCLUSIONS: In conclusion, SAF‐AGE(age) was positively associated with the prevalence of LBD/osteoporosis or MOFs in patients with T2DM. A positive association between SAF‐AGEs and the level of s‐PINP and s‐CTX was found.
format Online
Article
Text
id pubmed-9512774
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wiley Publishing Asia Pty Ltd
record_format MEDLINE/PubMed
spelling pubmed-95127742022-09-30 Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus Liu, Hongyan Wang, Guoqi Wu, Ting Hu, Jia Mu, Yiming Gu, Weijun J Diabetes Editor's Recommendation BACKGROUND: Advanced glycation end products (AGEs) that abnormally accumulate in diabetic patients have been reported to damage bone health. We aimed to investigate the association between skin autofluorescence (SAF)‐AGE(age) (SAF − AGEs × age/100) and low bone density (LBD)/osteoporosis or major osteoporotic fractures (MOFs) in patients with type 2 diabetes mellitus (T2DM). METHODS: This study was nested in the prospective REACTION (Risk Evaluation of Cancers in Chinese Diabetic Individuals) study and included 1214 eligible participants. SAF was used to measure skin AGEs (SAF‐AGEs). Fracture events were determined by an in‐person clinical follow‐up. Binary logistic regression analysis, linear regression analysis, and a restricted cubic spline nested in logistic models were used to test outcomes. RESULTS: The overall prevalence of LBD/osteoporosis in middle‐aged or elderly T2DM patients was 35.7% (n = 434), and the overall incidence of MOFs was 10.5% (n = 116). Logistic analysis showed a significantly positive relationship between quartiles of SAF‐AGE(age) and the risk of LBD/osteoporosis (odds ratio [OR] 2.02, 95% CI 1.34–3.03; OR 3.63, CI 2.44–5.39; and OR 6.51, CI 4.34–9.78) for the multivariate‐adjusted models, respectively. SAF‐AGE(age) was associated with MOFs with a multivariate‐adjusted OR of 1.02 (CI 0.52–2.02), 2.42 (CI 1.32–4.46), and 2.70 (CI 1.48–4.91), respectively. Stratified analyses showed that SAF‐AGE(age) was significantly associated with MOFs only in females, nonsmokers, nondrinkers, individuals with lower body mass index, and those without LBD/osteoporosis. Linear regression analyses showed that higher SAF‐AGEs were associated with a higher level of serum N‐terminal propeptide of type I procollagen (s‐PINP) and serum carboxy‐terminal cross‐linking peptide of type I collagen (s‐CTX), with a multivariate‐adjusted OR of 1.02 (CI 0.24–1.80) and 6.30 (CI 1.77–10.83), respectively. CONCLUSIONS: In conclusion, SAF‐AGE(age) was positively associated with the prevalence of LBD/osteoporosis or MOFs in patients with T2DM. A positive association between SAF‐AGEs and the level of s‐PINP and s‐CTX was found. Wiley Publishing Asia Pty Ltd 2022-09-04 /pmc/articles/PMC9512774/ /pubmed/36058895 http://dx.doi.org/10.1111/1753-0407.13309 Text en © 2022 The Authors. Journal of Diabetes published by Ruijin Hospital, Shanghai JiaoTong University School of Medicine and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editor's Recommendation
Liu, Hongyan
Wang, Guoqi
Wu, Ting
Hu, Jia
Mu, Yiming
Gu, Weijun
Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus
title Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus
title_full Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus
title_fullStr Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus
title_full_unstemmed Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus
title_short Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus
title_sort association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus
topic Editor's Recommendation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512774/
https://www.ncbi.nlm.nih.gov/pubmed/36058895
http://dx.doi.org/10.1111/1753-0407.13309
work_keys_str_mv AT liuhongyan associationofskinautofluorescencewithlowbonedensityosteoporosisandosteoporoticfracturesintype2diabetesmellitus
AT wangguoqi associationofskinautofluorescencewithlowbonedensityosteoporosisandosteoporoticfracturesintype2diabetesmellitus
AT wuting associationofskinautofluorescencewithlowbonedensityosteoporosisandosteoporoticfracturesintype2diabetesmellitus
AT hujia associationofskinautofluorescencewithlowbonedensityosteoporosisandosteoporoticfracturesintype2diabetesmellitus
AT muyiming associationofskinautofluorescencewithlowbonedensityosteoporosisandosteoporoticfracturesintype2diabetesmellitus
AT guweijun associationofskinautofluorescencewithlowbonedensityosteoporosisandosteoporoticfracturesintype2diabetesmellitus